51 min listen
Medicare Limitation of Aduhelm
ratings:
Length:
22 minutes
Released:
Jun 16, 2022
Format:
Podcast episode
Description
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
Released:
Jun 16, 2022
Format:
Podcast episode
Titles in the series (100)
October 16 2007 Issue: Disease-modifying therapies for Alzheimer disease: Challenges to early intervention by Neurology® Podcast